tiprankstipranks
Trending News
More News >
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
US Market

OptimizeRx (OPRX) Income Statement

Compare
579 Followers

OptimizeRx Income Statement

Last quarter (Q4 2025), OptimizeRx's total revenue was $32.24M, a decrease of -0.24% from the same quarter last year. In Q4, OptimizeRx's net income was $5.02M. See OptimizeRx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 109.43M$ 92.13M$ 71.52M$ 62.45M$ 61.29M
Gross Profit
$ 69.27M$ 59.38M$ 42.90M$ 38.97M$ 35.64M
Operating Expenses
$ 57.21M$ 73.08M$ 69.30M$ 51.26M$ 35.28M
Depreciation and Amortization
$ 4.33M$ 4.33M$ 2.40M$ 2.02M$ 1.97M
EBITDA
$ 16.39M$ -8.90M$ -21.31M$ -9.42M$ 2.33M
Operating Income
$ 12.06M$ -13.71M$ -26.40M$ -12.29M$ 361.10K
Other Income/Expenses
$ -5.11M$ -5.68M$ 1.24M$ 852.30K$ 16.98K
Pretax Income
$ 6.95M$ -19.39M$ -25.16M$ -11.44M$ 378.08K
Net Income
$ 5.13M$ -20.11M$ -17.57M$ -11.44M$ 378.08K
Per Share Metrics
Basic EPS
$ 0.28$ -1.10$ -1.03$ -0.64$ 0.02
Diluted EPS
$ 0.27$ -1.10$ -1.03$ -0.64$ 0.02
Weighted Average Shares Outstanding
18.56M 18.29M 17.12M 17.78M 17.23M
Weighted Average Shares Outstanding (Diluted)
19.00M 18.29M 17.12M 17.78M 17.69M
Currency in USD

OptimizeRx Earnings and Revenue History